Envestnet Portfolio Solutions’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$893K Sell
11,409
-72
-0.6% -$4.91K ﹤0.01% 757
2026
Q1
$742K Sell
11,481
-2,547
-18% -$180K ﹤0.01% 747
2025
Q4
$944K Buy
14,028
+485
+4% +$32.6K ﹤0.01% 781
2025
Q3
$993K Sell
13,543
-2,963
-18% -$197K ﹤0.01% 741
2025
Q2
$859K Buy
16,506
+5,214
+46% +$297K ﹤0.01% 851
2025
Q1
$721K Sell
11,292
-6,143
-35% -$357K ﹤0.01% 910
2024
Q4
$834K Sell
17,435
-446
-2% -$22.9K ﹤0.01% 1011
2024
Q3
$1.02M Buy
17,881
+6,414
+56% +$368K ﹤0.01% 884
2024
Q2
$600K Buy
11,467
+2,016
+21% +$88.4K ﹤0.01% 1059
2024
Q1
$384K Sell
9,451
-1,632
-15% -$61.2K ﹤0.01% 1223
2023
Q4
$410K Sell
11,083
-1,394
-11% -$52.5K ﹤0.01% 1131
2023
Q3
$477K Buy
+12,477
New +$511K ﹤0.01% 1007

Other funds holding HALO

Envestnet Portfolio Solutions's HALO Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Halozyme (HALO) stake by 0.63% in Q2 2026, selling an estimated $4.91K and leaving 11,409 shares worth $893K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Envestnet Portfolio Solutions first reported a position in HALO in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.02M in Q3 2024. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Envestnet Portfolio Solutions held 11,409 shares of Halozyme worth $893K as of Q2 2026.
  • Envestnet Portfolio Solutions sold 72 Halozyme shares in Q2 2026, an estimated $4.91K.
  • Halozyme made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #757 holding.
  • Envestnet Portfolio Solutions first reported a position in Halozyme in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Halozyme position peaked at $1.02M in Q3 2024.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.